# HMX2

## Overview
HMX2 is a gene that encodes the H6 family homeobox 2 protein, a transcription factor characterized by a homeobox domain, which is integral to its role in DNA binding and gene regulation. This protein is primarily involved in the development of sensory organs, particularly the inner ear, where it plays a crucial role in the morphogenesis of vestibular structures necessary for balance and hearing (Wang2004Hmx2; Miller2009Molecular). The HMX2 protein functions within the nucleus, influencing the transcription of target genes essential for organogenesis and cellular differentiation. Its evolutionary conservation is underscored by its functional parallels in species such as Drosophila (Wang2004Hmx2). Dysregulation of HMX2 has been implicated in various clinical conditions, including acute myeloid leukemia and congenital deafness, highlighting its significance in both normal development and disease (Nagel2020Aberrant; Sangu2016A).

## Structure
The HMX2 gene encodes a transcription factor that plays a significant role in developmental processes. The protein product of HMX2 features a homeobox domain, which is a critical component of its molecular structure. This domain is a DNA-binding motif that typically adopts a helix-turn-helix configuration, a common structural motif in transcription factors that facilitates DNA interaction.

The secondary structure of the HMX2 protein is characterized by this helix-turn-helix motif, which is essential for its function in binding to specific DNA sequences. This structural feature is crucial for the protein's role in regulating gene expression during development.

Post-translational modifications, such as phosphorylation, may regulate the activity of the HMX2 protein. These modifications can influence the protein's function by altering its conformation or interaction with other molecules, thereby modulating its activity in developmental pathways.

HMX2 also exhibits splice variant isoforms, which can lead to different versions of the protein with potentially altered functional properties. These isoforms may vary in their ability to bind DNA or interact with other proteins, thus impacting the gene's role in developmental processes.

## Function
HMX2 is a transcription factor involved in the development of sensory organs, particularly the inner ear. It is coexpressed with HMX3 in the dorsolateral otic epithelium during embryonic development, playing a crucial role in the transition of the otic placode to a fully developed vestibular system, which is essential for balance and hearing (Miller2009Molecular). In healthy human cells, HMX2 is expressed in the hypothalamus and otic region during embryonic development, controlling the development of the inner ear (Nagel2020Aberrant). The absence of HMX2, along with HMX3, in knockout mice leads to severe vestibular defects, including the absence of semicircular canals and other vestibular structures, indicating its critical role in inner ear morphogenesis (Wang2004Hmx2).

HMX2 is active in the nucleus, where it binds to DNA to regulate the transcription of target genes, contributing to proper organogenesis and cellular differentiation. This gene's function is conserved across species, as demonstrated by the ability of the Drosophila Hmx gene to partially rescue the function of mouse Hmx3, highlighting its evolutionary significance in sensory organ development (Wang2004Hmx2).

## Clinical Significance
Mutations and dysregulation of the HMX2 gene have been implicated in various clinical conditions. In acute myeloid leukemia (AML), aberrant expression of HMX2 is observed, particularly in patients with KMT2A-rearrangements. This aberrant expression is associated with interference in cell differentiation and activation of oncogenic pathways, contributing to leukemic transformation (Nagel2020Aberrant). HMX2, along with HMX3, is involved in the suppression of differentiation genes and activation of oncogenic pathways, such as the ERK pathway, which supports its role in myeloid differentiation arrest (Nagel2020Aberrant).

In the context of inner ear development, mutations in the HMX2 gene are linked to congenital deafness and balance dysfunctions. These mutations are part of microdeletions in the 10q26.1 region, which are associated with inner ear abnormalities and other developmental defects (Sangu2016A). HMX2 is suggested as a candidate gene responsible for these abnormalities due to its critical role in ear development (Steffes2012Mutanlallemand).

In colorectal cancer, particularly in African American patients, HMX2 is identified as a hypomethylated gene in neoplastic lesions, suggesting a role in colorectal carcinogenesis through its involvement in pathways like NF-kβ and TGF-β (Ashktorab2020Determination).


## References


[1. (Nagel2020Aberrant) Stefan Nagel, Claudia Pommerenke, Corinna Meyer, Roderick A. F. MacLeod, and Hans G. Drexler. Aberrant expression of nkl homeobox genes hmx2 and hmx3 interferes with cell differentiation in acute myeloid leukemia. PLOS ONE, 15(10):e0240120, October 2020. URL: http://dx.doi.org/10.1371/journal.pone.0240120, doi:10.1371/journal.pone.0240120. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0240120)

[2. (Wang2004Hmx2) Weidong Wang, J.Fredrik Grimmer, Thomas R. Van De Water, and Thomas Lufkin. Hmx2 and hmx3 homeobox genes direct development of the murine inner ear and hypothalamus and can be functionally replaced by drosophila hmx. Developmental Cell, 7(3):439–453, September 2004. URL: http://dx.doi.org/10.1016/j.devcel.2004.06.016, doi:10.1016/j.devcel.2004.06.016. This article has 106 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.devcel.2004.06.016)

[3. (Steffes2012Mutanlallemand) Georg Steffes, Beatriz Lorente-Cánovas, Selina Pearson, Rachael H. Brooker, Sarah Spiden, Amy E. Kiernan, Jean-Louis Guénet, and Karen P. Steel. Mutanlallemand (mtl) and belly spot and deafness (bsd) are two new mutations of lmx1a causing severe cochlear and vestibular defects. PLoS ONE, 7(11):e51065, November 2012. URL: http://dx.doi.org/10.1371/journal.pone.0051065, doi:10.1371/journal.pone.0051065. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0051065)

[4. (Ashktorab2020Determination) Hassan Ashktorab, Kareem Washington, Shatha Zarnogi, Afnan Shakoori, Sudhir Varma, Edward Lee, Babak Shokrani, Adeyinka Laiyemo, and Hassan Brim. Determination of distinctive hypomethylated genes in african american colorectal neoplastic lesions. Therapeutic Advances in Gastroenterology, 13:175628482090548, January 2020. URL: http://dx.doi.org/10.1177/1756284820905482, doi:10.1177/1756284820905482. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1177/1756284820905482)

[5. (Miller2009Molecular) Nathaniel D. Miller, Melonie A. Nance, Elizabeth S. Wohler, Julie E. Hoover‐Fong, Emily Lisi, George H. Thomas, and Jonathan Pevsner. Molecular (snp) analyses of overlapping hemizygous deletions of 10q25.3 to 10qter in four patients: evidence for hmx2 and hmx3 as candidate genes in hearing and vestibular function. American Journal of Medical Genetics Part A, 149A(4):669–680, March 2009. URL: http://dx.doi.org/10.1002/ajmg.a.32705, doi:10.1002/ajmg.a.32705. This article has 37 citations.](https://doi.org/10.1002/ajmg.a.32705)

[6. (Sangu2016A) Noriko Sangu, Nobuhiko Okamoto, Keiko Shimojima, Yumiko Ondo, Masanori Nishikawa, and Toshiyuki Yamamoto. A de novo microdeletion in a patient with inner ear abnormalities suggests that the 10q26.13 region contains the responsible gene. Human Genome Variation, May 2016. URL: http://dx.doi.org/10.1038/hgv.2016.8, doi:10.1038/hgv.2016.8. This article has 8 citations.](https://doi.org/10.1038/hgv.2016.8)